|
Amory, Colum F; Levine, Steven R; Brey, Robin L et al. (2015) Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis 40:293-300
|
|
Longstreth Jr, W T; Kronmal, Richard A; Thompson, John L P et al. (2013) Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke 44:714-9
|
|
Rajamani, Kumar; Chaturvedi, Seemant; Jin, Zhezhen et al. (2009) Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke 40:2337-42
|
|
Tanne, David; Macko, Richard F; Lin, Yan et al. (2006) Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke 37:1798-804
|
|
Gorman, Mark J; Jacobs, Bradley; Sloan, Michael et al. (2006) A web-based interactive database system for a transcranial Doppler ultrasound laboratory. J Neuroimaging 16:11-5
|
|
Chemerinski, Eran; Levine, Steven R (2006) Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med 73:1006-14
|
|
Levine, Steven R (2005) Hypercoagulable states and stroke: a selective review. CNS Spectr 10:567-78
|
|
Levine, Steven R (2004) Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail? J Neurol Sci 225:1-2
|
|
Schlegel, Daniel J; Tanne, David; Demchuk, Andrew M et al. (2004) Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol 61:1061-4
|
|
Levine, Steven R; Brey, Robin L; Tilley, Barbara C et al. (2004) Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 291:576-84
|
Showing the most recent 10 out of 26 publications
